Primitive Neuroectodermal Tumor — Trials

Primitive Neuroectodermal Tumor — Trials · CancerIndex

Clinical trials

Registered studies

673 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 146
Recruiting: 80
Ph III recruiting: 8
Growth YoY: −33.3%
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (86)

clinicaltrialsPublishedShowing 251–261 of 261 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00002748	Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma	completed	Phase 1	38	St. Jude Children's Research HospitalOTHER	1	Oct 4, 2011	clinicaltrials
NCT00053118	Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer	completed	Phase 1	1	Roswell Park Cancer InstituteOTHER	1	Mar 1, 2011	clinicaltrials